Is there any mention anywhere of what it has cost shareholders for an independent reviewer to tell us what we have already been told?
I would be happy if DDT raised $12 or $15 million and bought out Beston Technologies altogether. Instead, we are bound to be wrapped up with effectively another investee company, this time the biggest basket case company of them all.
All these fancy qualifications of the Board of Directors yet you have to wonder if any of them know that the idea of going in to business is to make money, not just faff around revaluing assets. That sort of practice was for the Bonds and Skases of the world.
After two and a half years, we now have a valuation, even after valuing up everything, that gives a same value per share as the float in 2015. The market says otherwise.
- Forums
- ASX - By Stock
- Ann: Independent Research Report issued on BFC
Is there any mention anywhere of what it has cost shareholders...
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BFC (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.991M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
BFC (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online